According to Robert H. Lorsch, MMRGlobal CEO, "Clearly, MMR's future is being built on our intellectual property assets patent by patent, which we believe will ultimately continue translating themselves into license agreements. In less than two years, we had already entered into a $13 million licensing agreement with Big Pharma"
and not one little bit on sales of existing products or services.
We are going to sue our way to the .... middle to lower end
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.